Ushercell HIV prevention study starts
This article was originally published in Pharmaceutical Approvals Monthly
Polydex/Conrad's Ushercell (cellulose sulfate) Phase III studies will test the microbicidal gel's efficacy in prevention of HIV and other sexually transmitted infections. The first HIV prevention study, cleared by FDA in summer 2004, is underway in Nigeria. "A second study's protocol has just been approved by the FDA and will be conducted by Conrad in several countries with a high incidence of HIV infection," Polydex says. Both placebo-controlled studies are enrolling HIV negative women who are at high-risk of contracting HIV through vaginal intercourse. Contraceptive studies of cellulose sulfate are ongoing...
You may also be interested in...
3D-printing company Carbon and in vitro diagnostics maker Resolution Medical announced plans to manufacture more than one million 3D-printed nasal swabs per week to test for COVID-19. See what Resolution Medical’s president Shawn Patterson said about it here.
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.